\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ conservative\\ management\ \(51\)\
\-\ \\â\\€\\¢\\ radiographic\ \(0\)\
\-\ 4\\.3\\ x\\ 3\\ cm\\ area\\ of\\ geographic\\ lytic\\ lesion\\ in\\ the\\ left\\ proximal\\ femoral\\ head\\.\ \(1\)\
\-\ \\â\\€\\¢\\ ct\ \(0\)\
\-\ geographic\\ sclerotic\\ and\\ lytic\\ lesion\\ in\\ the\\ left\\ femoral\\ head\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ scintigraphic\ \(0\)\
\-\ rim\\ of\\ intense\\ increased\\ radiotracer\\ uptake\\ in\\ the\\ left\\ femoral\\ head\\ with\\ central\\ photopenia\\ \\(doughnut\\ sign\\)\ \(0\)\
\-\ avascular\\ necrosis\\ of\\ the\\ femoral\\ head\ \(6\)\
\-\ \\â\\€\\¢\\ avascular\\ necrosis\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ or\\ primary\\ neoplastic\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ infection\ \(8\)\
\-\ \\â\\€\\¢\\ trauma\ \(16\)\
\-\ 52\\ y\\.o\\.\\ man\\ presents\\ with\\ trouble\\ urinating\\.\ \(1\)\
\-\ one\\ year\\ ago\\,\\ previously\\ presented\\ to\\ ed\\ for\\ left\\ hip\\ pain\\ with\\ radiographs\\ demonstrating\\ only\\ djd\\.\\ \\ medications\\ include\\ only\\ intermittent\\ nsaid\\ use\\ for\\ left\\ hip\\ pain\\.\\ \\(djd\\)\ \(0\)\
\-\ the\\ exact\\ cause\\ of\\ the\\ osteonecrosis\\ in\\ this\\ patient\\ is\\ not\\ definitively\\ known\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ djd\\:\\ 0\\.10176458329644457\ \(0\)\
\-\ femoral\\:\\ 0\\.1015936880201189\ \(0\)\
\-\ geographic\\:\\ 0\\.09173561632500091\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.08569609735290012\ \(0\)\
\-\ head\\:\\ 0\\.07573754095543425\ \(0\)\
\-\ avascular\\:\\ 0\\.07351007124676855\ \(0\)\
\-\ urinating\\:\\ 0\\.0634560253391137\ \(0\)\
\-\ lytic\\:\\ 0\\.05976696620605878\ \(0\)\
\-\ doughnut\\:\\ 0\\.05804081299098912\ \(0\)\
\-\ photopenia\\:\\ 0\\.05366881464774363\ \(0\)\
\-\ hip\\:\\ 0\\.053185505814241536\ \(0\)\
\-\ necrosis\\:\\ 0\\.05270469864757351\ \(0\)\
\-\ nsaid\\:\\ 0\\.050137680868501\ \(0\)\
\-\ trouble\\:\\ 0\\.04629020832867448\ \(0\)\
\-\ definitively\\:\\ 0\\.04404269213764494\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.04372377030545545\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.04312251217157945\ \(0\)\
\-\ exact\\:\\ 0\\.041321546088674506\ \(0\)\
\-\ osteonecrosis\\:\\ 0\\.04109508095685222\ \(0\)\
\-\ only\\:\\ 0\\.04014705716382712\ \(0\)\
\-\ left\\:\\ 0\\.03734786208097323\ \(0\)\
\-\ 52\\:\\ 0\\.03556905114785299\ \(0\)\
\-\ intense\\:\\ 0\\.035352023303266464\ \(0\)\
\-\ neoplastic\\:\\ 0\\.03416302474590767\ \(0\)\
\-\ radiotracer\\:\\ 0\\.03115003661456404\ \(0\)\
\-\ sclerotic\\:\\ 0\\.02988348310302939\ \(0\)\
\-\ medications\\:\\ 0\\.029777907172039368\ \(0\)\
\-\ demonstrating\\:\\ 0\\.02898103867238998\ \(0\)\
\-\ intermittent\\:\\ 0\\.028656437087133165\ \(0\)\
\-\ rim\\:\\ 0\\.028257979630474005\ \(0\)\
\-\ ed\\:\\ 0\\.028214935444450803\ \(0\)\
\-\ previously\\:\\ 0\\.028045091798853884\ \(0\)\
\-\ lesion\\:\\ 0\\.027196175406257104\ \(0\)\
\-\ conservative\\:\\ 0\\.026662820641361083\ \(0\)\
\-\ uptake\\:\\ 0\\.026523308005423532\ \(0\)\
\-\ use\\:\\ 0\\.026386243086275803\ \(0\)\
\-\ radiographic\\:\\ 0\\.02533878431084948\ \(0\)\
\-\ management\\:\\ 0\\.025191651901997198\ \(0\)\
\-\ ago\\:\\ 0\\.024849443912478505\ \(0\)\
\-\ n\\/a\\:\\ 0\\.024181301932492863\ \(0\)\
\-\ sign\\:\\ 0\\.023128488295031804\ \(0\)\
\-\ cause\\:\\ 0\\.022587989269937235\ \(0\)\
\-\ x\\:\\ 0\\.022023955744902166\ \(0\)\
\-\ central\\:\\ 0\\.02196586997546843\ \(0\)\
\-\ radiographs\\:\\ 0\\.021142740946891662\ \(0\)\
\-\ known\\:\\ 0\\.02112539909737359\ \(0\)\
\-\ area\\:\\ 0\\.021108095657298962\ \(0\)\
\-\ proximal\\:\\ 0\\.020043306107086056\ \(0\)\
\-\ primary\\:\\ 0\\.019776439553872628\ \(0\)\
\-\ infection\\:\\ 0\\.019406379484943805\ \(0\)\
\-\ y\\.o\\:\\ 0\\.019268589317083595\ \(0\)\
\-\ include\\:\\ 0\\.018727761625236615\ \(0\)\
\-\ trauma\\:\\ 0\\.01825788110748382\ \(0\)\
\-\ presented\\:\\ 0\\.018198106523612572\ \(0\)\
\-\ one\\:\\ 0\\.018091651432114407\ \(0\)\
\-\ cm\\:\\ 0\\.017905907170445202\ \(0\)\
\-\ metastatic\\:\\ 0\\.016805542215750705\ \(0\)\
\-\ increased\\:\\ 0\\.01633191235780981\ \(0\)\
\-\ pain\\:\\ 0\\.01630637761766773\ \(0\)\
\-\ man\\:\\ 0\\.01578853002414062\ \(0\)\
\-\ 3\\:\\ 0\\.01563262130239484\ \(0\)\
\-\ presents\\:\\ 0\\.013637846058655671\ \(0\)\
\-\ in\\:\\ 0\\.013168663441882967\ \(0\)\
\-\ for\\:\\ 0\\.011392314822542424\ \(0\)\
\-\ \\(\\:\\ 0\\.01128690197256032\ \(0\)\
\-\ \\)\\:\\ 0\\.011149026439270392\ \(0\)\
\-\ disease\\:\\ 0\\.010912012040747689\ \(0\)\
\-\ not\\:\\ 0\\.00964702087298387\ \(0\)\
\-\ ct\\:\\ 0\\.009338309792125335\ \(0\)\
\-\ or\\:\\ 0\\.007824396476278965\ \(0\)\
\-\ this\\:\\ 0\\.007508884479016664\ \(0\)\
\-\ year\\:\\ 0\\.007469572416194646\ \(0\)\
\-\ patient\\:\\ 0\\.006692124460284281\ \(0\)\
\-\ the\\:\\ 0\\.006480435220482459\ \(0\)\
\-\ is\\:\\ 0\\.004392896706130669\ \(0\)\
\-\ of\\:\\ 0\\.0036407437749371384\ \(0\)\
\-\ to\\:\\ 0\\.00333646959721083\ \(0\)\
\-\ with\\:\\ 0\\.002742285377106791\ \(0\)\
\-\ \\,\\:\\ 0\\.0021149223868538077\ \(0\)\
\-\ \\.\\:\\ 0\\.0019413808803236245\ \(0\)\
\-\ and\\:\\ 0\\.0014063203572829567\ \(0\)\
